Source: Pharamceutical Technology

Neurona Therapeutics received $102M in Equity Funding

Read full article »

Neurona Therapeutics's Competitors | Neurona Therapeutics's News | Neurona Therapeutics's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

Co-Founder & CEO

Cory R. Nicholas

CEO Approval Rating

90/100

Neurona is a California-based biotechnology company that researches and develops regenerative cell therapies for the treatment of chronic neurological disorders.